These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7181479)

  • 41. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the E test (PDM epsilometer) and broth microdilution susceptibility tests for members of the Bacteroides fragilis group.
    Murray PR; Niles AC
    Diagn Microbiol Infect Dis; 1991; 14(6):501-5. PubMed ID: 1802537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of cefoxitin-resistant isolates of bacteroides to other agents including beta-lactamase inhibitor/beta-lactam combinations.
    Cherubin CE; Appleman MD
    J Antimicrob Chemother; 1993 Jul; 32(1):168-71. PubMed ID: 8226410
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro activity of sanguinarine against oral microbial isolates.
    Dzink JL; Socransky SS
    Antimicrob Agents Chemother; 1985 Apr; 27(4):663-5. PubMed ID: 4004199
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
    Nagy E; Szóke I; Gacs M; Csiszár K
    Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis.
    Dornbusch K; Nord CE; Wadström T
    Scand J Infect Dis; 1974; 6(3):253-8. PubMed ID: 4496865
    [No Abstract]   [Full Text] [Related]  

  • 50. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial susceptibilities of Eubacterium, Peptostreptococcus, and Bacteroides isolated from root canals of teeth with periapical pathosis.
    Yamamoto K; Fukushima H; Tsuchiya H; Sagawa H
    J Endod; 1989 Mar; 15(3):112-6. PubMed ID: 2607278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
    De Almeida AE; De Uzeda M
    Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia.
    Shilnikova II; Dmitrieva NV
    Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp.
    Guiney DG; Bouic K
    J Bacteriol; 1990 Jan; 172(1):495-7. PubMed ID: 2294095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial activity of various antibiotics against oral streptococci isolated in the oral cavity.
    Pasquantonio G; Condò S; Cerroni L; Bikiqu L; Nicoletti M; Prenna M; Ripa S
    Int J Immunopathol Pharmacol; 2012; 25(3):805-9. PubMed ID: 23058035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
    Crosby MA; Gump DW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):398-405. PubMed ID: 6291451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging metronidazole resistance in Bacteroides spp. and its association with the nim gene: a study from North India.
    Sethi S; Shukla R; Bala K; Gautam V; Angrup A; Ray P
    J Glob Antimicrob Resist; 2019 Mar; 16():210-214. PubMed ID: 30342928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
    Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of the Bacteroides fragilis group in community hospitals.
    File TM; Thomson RB; Tan JS; Salstrom SJ; Jacobs GA; Johnson L; Tan L
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):317-22. PubMed ID: 3465493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.